Advanced technology and the latest AI-based innovation to transform cardiology practice
Implicity aspires to leverage cardiology practice and design predictive solutions for tomorrow by combining state-of-the-art software technology with data science, machine learning and artificial intelligence. Our commitment is to extend the reach and efficiency of cardiac remote monitoring using innovative solutions to improve patient care.
SaaS cloud-based, our AI-driven platform automates remote monitoring of implanted cardiac devices
Implicity remote monitoring platform was designed by an electrophysiologist to provide hospital teams with a complete solution to effectively monitor their patients and provide them with an optimal quality care.
One universal and unified platform aggregating data from all manufacturers’ devices.
Customized reports for your in-clinic visits and remote monitoring follow-up.
Prioritized alerts based on customized parameters, making triage easier.
Patient history automatically available and clearly displayed via the patient timeline.
Research & Innovation
Accelerate research and serve the future of preventive cardiology
Implicity is partnering with clinicians and researchers to identify patterns for research. We leverage real-world data analytics to accelerate healthcare research and innovation.
Improving patient care in 70+ medical centers in Europe, US and Canada.
70+ Medical Centers
Healthcare facilities worldwide chose Implicity to improve clinic operations and provide better patient care.
Implicity platform represents the medicine of tomorrow. The challenge today is to sort out the mass of information that doctors receive and effectively manage this influx of data. It necessarily involves AI and IT. We are witnessing a revolution and a digital transformation towards a predictive and personalized medicine.
Award & Prize Winner
Prize Winner Bridgehead Europe
Laureate Health Data Hub
With the project Hydro
Innovative company label
Laureate of I-Lab
Contest (19th edition)
Laureate of Digital Innovation
Contest (with the project HF-Guard)
Société Française de Télémédecine
Documentation & Publication
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia. AF is a significant burden to healthcare professional and the society in general, with an increased risk of stroke and embolism. Its incidence varies with age from 1.7% for the youngest to 23.4% for the...
Find out all our news, events and future projects
Discover our new AI solution:
ILR ECG Analyzer*
Boost medical staff productivity by focusing on meaningful cardiac arrhythmia events
* FDA approved Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information.